Published in:
Volume 5 / Year 2016 / Issue 2

Biosimilars patent litigation in Canada and Japan: a comparative strategic overview and EU and US update

Author(s): ,
Page: 60-5

Abstract: Biosimilars are highly similar versions of reference biological products, some with the potential to be deemed ‘interchangeable’ by medicines regulatory bodies, such as the US Food and Drug Administration.… Read More »

Go Back Print